NORTH BRUNSWICK, N.J.--(BUSINESS WIRE)--Advaxis, Inc., (OTCBB: ADXS), the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company, appoints Dr. Robert Petit, PhD, to the newly created position of vice president of Clinical Operations and Medical Affairs, effective October 11, 2010. Dr. Petit will report to Dr. John Rothman, EVP of Science and Operations.
